Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model

Molibresib (GSK525762) is an investigational, orally bioavailable, small‐molecule bromodomain and extraterminal (BET) protein inhibitor for the treatment of advanced solid tumors. Molibresib was initially evaluated in a first‐time‐in‐human (FTIH) study BET115521 consisting of two parts: Part 1 of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnatry, Anu Shilpa, Voelkner, Alexander, Dhar, Arindam, Prohn, Marita, Ferron‐Brady, Geraldine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302244/
https://www.ncbi.nlm.nih.gov/pubmed/33955700
http://dx.doi.org/10.1002/psp4.12639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302244/
https://www.ncbi.nlm.nih.gov/pubmed/33955700
http://dx.doi.org/10.1002/psp4.12639

Ejemplares similares